PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs
Visit https://www.peervoice.com/VXJ860 to view the entire programme with slides. After completing “Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAs”, participants will be able to: Recognise the burden of stroke in patients with type 2 diabetes mellitus (T2DM) and opportunities to improve primary and secondary prevention; Design treatment regimens for T2DM in accordance with national guidelines which will optimise cardiovascular benefits and stroke risk reduction; and Identify strategies to improve stroke prevention and use of GLP-1 receptor agonists (RAs) through collaborative multidisciplinary management.